Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic ImplantsBusiness Wire • 10/13/23
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/08/23
Establishment Labs to Announce Second Quarter 2023 Financial Results on August 8Business Wire • 07/26/23
Establishment Labs Celebrates Opening of Sulàyöm Innovation Campus and Outlines New and Expanded CapabilitiesBusiness Wire • 07/19/23
Establishment Labs Announces CE Mark Approval for Minimally Invasive Surgical ToolsBusiness Wire • 05/30/23
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue EstimatesZacks Investment Research • 05/08/23
Establishment Labs Announces Closing of Public Offering of Common Shares and Full Exercise of Underwriters' Option to Purchase Additional SharesBusiness Wire • 04/27/23
Establishment Labs Announces Preliminary Unaudited Results for First Quarter 2023Business Wire • 04/24/23
Establishment Labs Notes Presentation of 3-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2023Business Wire • 04/20/23
Establishment Labs Begins a New Era in Breast Aesthetics with Launch of Mia Femtech in JapanBusiness Wire • 04/10/23
Establishment Labs Holdings Inc. (ESTA) Stock Jumps 6.1%: Will It Continue to Soar?Zacks Investment Research • 04/04/23
Establishment Labs Announces First Mia Femtech™ Partners in Europe and Second Partner Chain in JapanBusiness Wire • 03/23/23
ESTA INVESTOR NOTICE: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Establishment Labs Holdings Inc. Investors to Inquire About Securities Class Action Investigation – ESTABusiness Wire • 03/02/23
ROSEN, A LEADING LAW FIRM, Encourages Establishment Labs Holdings Inc. Investors with Losses to Inquire About Securities Class Action Investigation - ESTAPRNewsWire • 03/01/23
Establishment Labs to Present at the Cowen 43rd Annual Health Care ConferenceBusiness Wire • 02/28/23